TY - JOUR
T1 - Deposition patterns of ragweed pollen in the human respiratory tract
AU - Martonen, T. B.
AU - O’Rourke, M. K.
N1 - Funding Information:
A portion of this work was fundcd by Environmental Pro- tection Agency Contract #CR811806 to Michael D. Lebo-witt. We thank Barbara Albright for the final typing of this manuscript. Disclaimer: Although the research described in this article has been supported by the United States Environmental Protection Agency, it has not been sub- jected to Agency rcvicw and therefore does not necessarily reflect thc views of the Agency and no official endorsement should be inferred. hlention of trade names or commercial products does not constitute endorsement or recommendation for use.
PY - 1991
Y1 - 1991
N2 - Inhaled particle deposition sites must be identified to effectively treat human airway diseases. We have determined distribution patterns of a selected aeroallergen, ragweed pollen, among human extrathoracic (ET: i.e., oro-nasopharyngcal) regions and the lung. A predictive model validated by inhalation exposure data from human subjects was utilized. Deposition locations were primarily functions of 1. ragweed particle parameters (size: 14-20 im, shape: spherical, and density: 1.14 g cm-3) and 2. mode of breathing. In the general population, two styles of inhalation are prevalent: normal augmentors (NAs), and mouth breathers (MBs), their clinical definitions arc based on intra-ET airflow divisions. For a NA-mode breathing, sedentary (10 L min-1) adult, 88% of inhaled ragweed pollen was removed by the ET compartment and 7% collected within the lung. For a MB, the respective deposition efficiencies were 68% and 25%. To apply the model, we used a daily springtime ragweed pollen concentration of 300 grains m-3 and an exposure time of 0.5 hour to calculate actual doses for the respiratory system. Under the stipulated conditions, a MB would inhale 45 pollen grains per day and 8 would be deposited in the lung; the value is 3 grains for a NA. Frequently, individuals with impaired respiratory functions are MBs in whom such pollen deposits are likely contributors to airway disease.
AB - Inhaled particle deposition sites must be identified to effectively treat human airway diseases. We have determined distribution patterns of a selected aeroallergen, ragweed pollen, among human extrathoracic (ET: i.e., oro-nasopharyngcal) regions and the lung. A predictive model validated by inhalation exposure data from human subjects was utilized. Deposition locations were primarily functions of 1. ragweed particle parameters (size: 14-20 im, shape: spherical, and density: 1.14 g cm-3) and 2. mode of breathing. In the general population, two styles of inhalation are prevalent: normal augmentors (NAs), and mouth breathers (MBs), their clinical definitions arc based on intra-ET airflow divisions. For a NA-mode breathing, sedentary (10 L min-1) adult, 88% of inhaled ragweed pollen was removed by the ET compartment and 7% collected within the lung. For a MB, the respective deposition efficiencies were 68% and 25%. To apply the model, we used a daily springtime ragweed pollen concentration of 300 grains m-3 and an exposure time of 0.5 hour to calculate actual doses for the respiratory system. Under the stipulated conditions, a MB would inhale 45 pollen grains per day and 8 would be deposited in the lung; the value is 3 grains for a NA. Frequently, individuals with impaired respiratory functions are MBs in whom such pollen deposits are likely contributors to airway disease.
UR - https://www.scopus.com/pages/publications/79957853357
UR - https://www.scopus.com/pages/publications/79957853357#tab=citedBy
U2 - 10.1080/00173139109427776
DO - 10.1080/00173139109427776
M3 - Article
AN - SCOPUS:79957853357
SN - 0017-3134
VL - 30
SP - 82
EP - 86
JO - GRANA
JF - GRANA
IS - 1
ER -